IRIS
BELLOCCHI, MARIA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.521
EU - Europa 1.099
AS - Asia 526
SA - Sud America 8
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 12.165
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.513
SG - Singapore 359
IT - Italia 280
DE - Germania 131
UA - Ucraina 116
SE - Svezia 113
IE - Irlanda 110
CN - Cina 100
RU - Federazione Russa 91
PL - Polonia 69
FR - Francia 67
GB - Regno Unito 47
FI - Finlandia 39
KR - Corea 35
BE - Belgio 15
CZ - Repubblica Ceca 14
IN - India 7
CA - Canada 6
HK - Hong Kong 6
JP - Giappone 5
VN - Vietnam 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
CH - Svizzera 3
CL - Cile 3
CM - Camerun 2
EU - Europa 2
MN - Mongolia 2
MX - Messico 2
MY - Malesia 2
NL - Olanda 2
PE - Perù 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
GH - Ghana 1
ID - Indonesia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ZA - Sudafrica 1
ZW - Zimbabwe 1
Totale 12.165
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.877
Wilmington 2.711
Houston 2.432
Fairfield 399
Singapore 311
Chandler 281
Ann Arbor 225
Ashburn 180
Seattle 171
Rome 164
Cambridge 130
Dublin 104
Jacksonville 98
Santa Clara 88
Medford 80
New York 72
Creede 71
Kraków 69
Beijing 48
Dearborn 45
Lawrence 36
Milan 25
San Diego 25
Colorado Springs 22
Moscow 18
Mülheim 18
Munich 17
Brussels 15
Zhengzhou 15
Helsinki 12
Menlo Park 12
Mountain View 12
Brno 9
London 9
Redwood City 9
Guangzhou 8
Boardman 7
Falls Church 7
Florence 7
Magenta 7
Nuremberg 7
Hong Kong 6
Seoul 6
Cedarhurst 5
Dong Ket 5
Los Angeles 5
Norwalk 5
Olomouc 5
Palo Alto 5
University Park 5
Binasco 4
Cagliari 4
Kunming 4
Phoenix 4
Saint Petersburg 4
San Mateo 4
Verona 4
Chiswick 3
Detroit 3
Fuzhou 3
Hounslow 3
La Veta 3
Mumbai 3
North Hollywood 3
Padova 3
The Dalles 3
Toronto 3
Acton 2
Albano Laziale 2
Bagnoregio 2
Bologna 2
Council Bluffs 2
Engelhard 2
Hefei 2
Jinan 2
Kyiv 2
Lappeenranta 2
Lima 2
Milazzo 2
Montréal 2
Nanchang 2
Nanjing 2
Nepi 2
Paris 2
Pune 2
Sacramento 2
San Francisco 2
Shanghai 2
Shaoxing 2
Sungai Petani 2
São Paulo 2
Tokyo 2
Villafranca Padovana 2
Wuhan 2
Yaoundé 2
Zinacatepec 2
Zurich 2
Adliswil 1
Almaty 1
Amsterdam 1
Totale 11.021
Salva come PNG Salva come JPEG
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 512
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 472
Virologic correlates of adherence to antiretroviral medications and therapeutic failure 461
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso 446
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 446
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 438
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 429
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases 424
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors 423
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 420
Population variation analysis at nine loci containing expressed trinucleotide repeats 418
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 414
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso 406
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy 405
Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme 393
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 387
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy 386
Incomplete APOBEC3G/F neutralization by HIV-1 Vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage 386
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients with Acute Hepatitis B 377
Dynamics of NRTI resistance mutations during therapy interruption 375
Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors 367
Temporal change in the use of genotypic resistance testing over the years 1999--2003 367
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir 363
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 346
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 343
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 340
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 255
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 184
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 169
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients 155
Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation 119
HHV-8 genetic diversification and its impact on severe clinical presentation of associated diseases 68
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 66
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 62
Impact of analytical treatment interruption on burden and diversification of HIV peripheral reservoir: a pilot study 60
Characterization of HBV and HCV minority quasispecies by Ultra-Deep Pyrosequencing analysis: impact on pathogenicity and response to antiviral drugs 59
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 57
SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 50
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects 40
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 39
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 39
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 38
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario? 37
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 33
Genetic heterogenicity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients 29
Factors predictive of virological response after genotyping resistance test (GRT): data from an unselected cohort 26
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy 25
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 25
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 24
Using a database of genotype resistance tests to describe characteristics related to detection of the multinucleoside resistance-associated Q151M mutation. 21
Factors predictive of multinucleoside analogue-resistance mutations in an unselected cohort of HAART-failed patients. 21
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies 18
Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase 17
Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors 17
Time to detection and loss of M184 genotypic mutation among HIV patients treated with 3TC and failing an HAART regimen 16
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 16
Long-term evaluation of the effect of genotype-based antiretroviral therapy upon virological, immunological, and clinical parameters 15
Cross-resistance among NNRTIs: evaluation of the option of recycling Efavirenz after Nevirapine failure 14
Identification of the Minimal Conserved Structure of the HIV-Reverse Transcriptase under the Presence and Absence of Drug Pressure 13
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation 12
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 11
First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus 10
Totale 12.404
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.087 0 0 0 0 249 327 267 259 285 284 199 217
2020/20211.956 217 240 235 234 203 207 235 179 38 69 67 32
2021/2022546 37 45 33 31 20 35 25 22 119 43 24 112
2022/2023904 75 66 53 87 49 129 39 234 52 69 40 11
2023/2024337 54 8 28 16 31 90 10 11 12 20 4 53
2024/2025770 66 357 177 138 32 0 0 0 0 0 0 0
Totale 12.404